SCHEMBL2014812

SCHEMBL2014812

Cc1cccc(C(=O)NCC[C@H](Cc2ccccc2)N(C)C(=O)c2ccnc(C)n2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.43
HCRTR2 O43614 2/20 0.43
EPHX2 P34913 1/20 0.38
P2RX7 Q99572 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRK1 P41145 1/20 0.38
TMEM97 Q5BJF2 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
LMNA P02545 3/20 0.37
KDM4E B2RXH2 1/20 0.37
CTSA P10619 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 1/20 0.36
ATM Q13315 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HTR1A P08908 1/20 0.35
HTR2A P28223 1/20 0.35
CNR1 P21554 1/20 0.35
HPGD P15428 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2014681 1.00 HCRTR1 (0.43) HCRTR1HCRTR2EPHX2P2RX7OPRM1
SCHEMBL2014592 0.89 HCRTR1 (0.43) HCRTR1HCRTR2EPHX2P2RX7OPRM1
SCHEMBL2011408 0.89 HCRTR1 (0.43) HCRTR1HCRTR2EPHX2OPRM1OPRK1
SCHEMBL2051291 0.89 HCRTR1 (0.43) HCRTR1HCRTR2EPHX2P2RX7OPRM1
SCHEMBL2013196 0.81 HCRTR1 (0.42) HCRTR1HCRTR2LMNAALDH1A1MAPT
SCHEMBL2010539 0.81 HCRTR1 (0.63) HCRTR1HCRTR2P2RX7SMN1; SMN2HPGD
SCHEMBL2012798 0.81 HCRTR1 (0.48) HCRTR1HCRTR2P2RX7OPRM1OPRK1
SCHEMBL2017304 0.80 HCRTR1 (0.43) HCRTR1HCRTR2EPHX2OPRM1OPRK1
SCHEMBL6919106 0.80 HCRTR1 (0.43) HCRTR1HCRTR2EPHX2OPRM1OPRK1
SCHEMBL2013858 0.79 HCRTR1 (0.46) HCRTR1HCRTR2P2RX7OPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed